Artigo Revisado por pares

The adjunctive use of Angio-Seal in femoral vascular closure following percutaneous transcatheter aortic valve replacement

2016; European Association of Percutaneous Cardiovascular Interventions; Volume: 12; Issue: 1 Linguagem: Inglês

10.4244/eijv12i1a16

ISSN

1969-6213

Autores

Sarkis Kiramijyan, Marco A. Magalhães, Itsik Ben‐Dor, Edward Koifman, Ricardo O. Escárcega, Nevin C. Baker, Rebecca Torguson, Petros Okubagzi, Nelson L. Bernardo, Lowell F. Satler, Augusto D. Pichard, Ron Waksman,

Tópico(s)

Infective Endocarditis Diagnosis and Management

Resumo

The objective of this study was to describe and evaluate the adjunctive technique of Angio-Seal (AS) use to augment the dual Perclose ProGlide (PP) in achieving haemostasis in patients undergoing transfemoral percutaneous transcatheter aortic valve replacement (TAVR).All patients who underwent TAVR from May 2007 to January 2015 via a planned transfemoral percutaneous approach with a dual PP pre-close strategy were retrospectively analysed. This cohort was divided into two groups: dual PP versus dual PP with adjunctive AS (PP+AS) use based on the specific status of intraprocedural haemostasis. The baseline and procedural characteristics and in-hospital outcomes were prospectively collected and retrospectively compared. Overall, a total of 387 consecutive patients (55% male, mean age 83 years) with dual PP (n=179) vs. dual PP+AS (n=208) were evaluated. There were no statistically significant differences between the dual PP vs. dual PP+AS groups with regard to the in-hospital Valve Academic Research Consortium-2 (VARC-2) primary endpoints of major vascular complications (8.0% vs. 6.6%, p=0.592), minor vascular complications (18.4% vs. 13.7%, p=0.218), life-threatening or disabling bleeding (5.1% vs. 3.0%, p=0.291), major bleeding (1.7% vs. 1.5%, p=1.000), and minor bleeding (14.4% vs. 10.6%, p=0.271).The adjunctive Angio-Seal technique to augment the dual PP pre-close strategy for patients undergoing percutaneous femoral closure following TAVR is feasible and safe and may be considered as a bail-out or an alternative strategy when the dual PP closure technique fails to obtain complete haemostasis.

Referência(s)
Altmetric
PlumX